Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Savinelli

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Clinics and Research in Hepatology and Gastroenterology|June 6, 2017
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfectionClaudia Mascia, Miriam Lichtner, Paola Zuccalà, et al.
International Journal of Molecular Sciences|October 14, 2022
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected SubjectsPaola Zuccalà, Tiziana Latronico, Raffaella Marocco, et al.
Journal of Infection in Developing Countries|January 22, 2024
TB specific intracellular cytokines production in Synovial liquid for diagnosis of tuberculous arthritisSerena Vita, Claudia Mascia, Blerta Kertusha, et al.
Journal of Immunology Research|April 8, 2020
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV InfectionSerena Vita, Paola Zuccalà, Stefano Savinelli, et al.
Immunobiology|December 8, 2018
Myeloid and lymphoid activation markers in AIDS and non-AIDS presentersMarco Iannetta, Stefano Savinelli, Raffaella Rossi, et al.
Respirology (Carlton, Vic.)|July 23, 2020
Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory stateCormac McCarthy, Stefano Savinelli, Eoin R Feeney, et al.
BMC Infectious Diseases|November 17, 2023
Impact of vaccination and variants of concern on long COVID clinical phenotypesGrace Kenny, Kathleen McCann, Conor O'Brien, et al.
Ebiomedicine|February 23, 2025
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccinationJoanne Byrne, Gurvin Saini, Alejandro Garcia-Leon, et al.
Open Forum Infectious Diseases|September 29, 2025
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic VaccinationJoanne Byrne, Alejandro Garcia-Leon, Aisling Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2020
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" StudyAndrea Gori, Andrea Antinori, Alessandra Vergori, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Clinics and Research in Hepatology and Gastroenterology|June 6, 2017
Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfectionClaudia Mascia, Miriam Lichtner, Paola Zuccalà, et al.
International Journal of Molecular Sciences|October 14, 2022
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected SubjectsPaola Zuccalà, Tiziana Latronico, Raffaella Marocco, et al.
Journal of Infection in Developing Countries|January 22, 2024
TB specific intracellular cytokines production in Synovial liquid for diagnosis of tuberculous arthritisSerena Vita, Claudia Mascia, Blerta Kertusha, et al.
Journal of Immunology Research|April 8, 2020
Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV InfectionSerena Vita, Paola Zuccalà, Stefano Savinelli, et al.
Immunobiology|December 8, 2018
Myeloid and lymphoid activation markers in AIDS and non-AIDS presentersMarco Iannetta, Stefano Savinelli, Raffaella Rossi, et al.
Respirology (Carlton, Vic.)|July 23, 2020
Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory stateCormac McCarthy, Stefano Savinelli, Eoin R Feeney, et al.
BMC Infectious Diseases|November 17, 2023
Impact of vaccination and variants of concern on long COVID clinical phenotypesGrace Kenny, Kathleen McCann, Conor O'Brien, et al.
Ebiomedicine|February 23, 2025
Development and validation of a quantitative Orthopoxvirus immunoassay to evaluate and differentiate serological responses to Mpox infection and vaccinationJoanne Byrne, Gurvin Saini, Alejandro Garcia-Leon, et al.
Open Forum Infectious Diseases|September 29, 2025
Antibody Responses are Sustained 2 Years Post-Mpox Infection but not Following Modified Vaccinia Ankara-Bavarian Nordic VaccinationJoanne Byrne, Alejandro Garcia-Leon, Aisling Murphy, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2020
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" StudyAndrea Gori, Andrea Antinori, Alessandra Vergori, et al.
Pageof 4